Taltz 80 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FMXJK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,949
Award facts
- Contract value 100% obligated
- $17,948.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 8, 2025, for the supply of TALTZ 80 mg/ml autoinjector units. This firm fixed price delivery order, valued at $17,948.56, has an ultimate completion date of August 11, 2025, and represents a non-competitive, open-market award. The Defense Logistics Agency, which manages the military's medical supply chain, is the funding federal agency. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat autoimmune inflammatory conditions. The award demonstrates AmerisourceBergen's ongoing critical role in supporting military healthcare systems through the DLA Troop Support Medical contract, which enables the company to supply a broad portfolio of specialty medications, brand-name and generic drugs, and medical supplies to Defense Health Agency customers and other federal healthcare systems worldwide. The company's extensive contract history with DLA reflects its established capability to fulfill federal medical procurement requirements for specialized pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FMXJK?
SPE2DB25FMXJK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FMXJK worth?
The government has obligated $17,949 on SPE2DB25FMXJK.
Is contract SPE2DB25FMXJK an order under another contract?
Yes. SPE2DB25FMXJK is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMXJK competed?
The extent of competition for SPE2DB25FMXJK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award